# Medical AI Diagnosis Research Notes

## Papers Analyzed (2026-05-06)

### DeepMedix-R1 (arxiv:2509.03906)
- **Problem**: Clinical adoption of AI hampered by black-box nature
- **Solution**: Foundation model for CXR with clinical reasoning traces
- **Key Innovation**: Generates diagnoses + step-by-step clinical reasoning
- **Impact**: Addresses the trust barrier in medical AI adoption

### Skin Lesion Diagnosis (arxiv:2601.00964)
- **Approach**: Deep learning for automated skin lesion classification
- **Clinical Value**: Early detection of skin cancer
- **Pattern**: Image classification → differential diagnosis

### MRI Spine Pathology (arxiv:2503.20316)
- **System**: Computer-aided detection for spinal abnormalities
- **Capabilities**: Classification, segmentation, localization
- **Pattern**: Multi-task learning (detect + segment + classify)

### Oncology AI (arxiv:2501.15489)
- **Scope**: Cancer detection across multiple types (lung, breast, etc.)
- **Focus**: Precision diagnosis and personalized therapy
- **Pattern**: Multi-cancer detection with treatment recommendations

## Common Patterns Across Papers

1. **Explainability is non-negotiable** for clinical adoption
2. **Multi-modal data** improves diagnostic accuracy
3. **Foundation models** are becoming the standard approach
4. **Human-in-the-loop** design is critical for safety
5. **External validation** across diverse populations is essential

## Implementation Checklist

- [ ] Define clinical use case and target population
- [ ] Collect multi-modal training data with expert annotations
- [ ] Choose appropriate architecture (CNN, Transformer, Foundation Model)
- [ ] Implement explainability layer (attention maps, reasoning traces)
- [ ] Add uncertainty quantification
- [ ] Validate internally (cross-validation)
- [ ] Validate externally (different site/population)
- [ ] Clinical validation with expert comparison
- [ ] Regulatory compliance (FDA, CE marking if applicable)
